Outlook Therapeutics Inc. buy BiotechBee
Start price
06.02.23
/
60%
€1.18
Target price
31.12.25
€2.00
Performance (%)
-15.64%
End price
05.05.23
€1.00
Summary
This prediction ended on 05.05.23 with a price of €1.00. The prediction for Outlook Therapeutics Inc. disappointed with a performance of -15.64%. BiotechBee has 60% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Outlook Therapeutics Inc. | - | - | - |
iShares Core DAX® | 1.665% | 0.362% | 17.556% |
iShares Nasdaq 100 | -0.475% | -3.195% | 26.812% |
iShares Nikkei 225® | 2.620% | 1.174% | 17.273% |
iShares S&P 500 | -0.091% | -1.597% | 24.739% |
According to BiotechBee what are the pros and cons of Outlook Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Outlook Therapeutics Inc. diskutieren
Buy mit Kursziel 2,0
In the thread Trading Outlook Therapeutics Inc.
Buy beendet